Htlv among israeli intravenous drug abusers

S. Maayan, M. Dan, R. Marline, Y. M. Chen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Maayan S (Department of Clinical Microbiology, Hadassah University Hospital, Jerusalem, Israel), Dan M, Marlink R and Chen Y M. HTLV among Israeli intravenous drug abusers. International Journal of Epidemiology 1992; 21: 995-997 Since human T lymphotropic virus (HTLV) infection was recently described in Israel and other Middle Eastern countries, we have investigated the presence of HTLV type 1 and type 2 in a group of 299 intravenous (IV) drug abusers who were seen at a large methadone clinic in the Tel Aviv area in 1986-1987. We found that 1.3% were seropositive to HTLV. Further testing revealed that HTLV1 was the only HTLV serotype. In addition, no coinfection HIV1/HTLV1 and no HIV2 infection were detected. Since all HTLV séropositives were bom in Middle Eastern countries, did not travel outside Israel and were not infected by HIV1 or by HTLV type 2, it is possible that the source of HTLV1 infection in that group was in an endemic reservoir of HTLV1 in Israel. The detection of HTLV1 among IV drug abusers and among other groups in Israel necessitates more extensive HTLV testing in at-risk populations.

Original languageEnglish
Pages (from-to)995-997
Number of pages3
JournalInternational Journal of Epidemiology
Volume21
Issue number5
DOIs
Publication statusPublished - Jan 1 1992
Externally publishedYes

Fingerprint

Drug Users
Israel
Viruses
Human T-lymphotropic virus 2
Human T-lymphotropic virus 1
Methadone
Virus Diseases
Microbiology
Infection
Coinfection
Epidemiology

ASJC Scopus subject areas

  • Epidemiology

Cite this

Htlv among israeli intravenous drug abusers. / Maayan, S.; Dan, M.; Marline, R.; Chen, Y. M.

In: International Journal of Epidemiology, Vol. 21, No. 5, 01.01.1992, p. 995-997.

Research output: Contribution to journalArticle

Maayan, S. ; Dan, M. ; Marline, R. ; Chen, Y. M. / Htlv among israeli intravenous drug abusers. In: International Journal of Epidemiology. 1992 ; Vol. 21, No. 5. pp. 995-997.
@article{133bcf4e66cd4bb0b2329d2d5ef3eec9,
title = "Htlv among israeli intravenous drug abusers",
abstract = "Maayan S (Department of Clinical Microbiology, Hadassah University Hospital, Jerusalem, Israel), Dan M, Marlink R and Chen Y M. HTLV among Israeli intravenous drug abusers. International Journal of Epidemiology 1992; 21: 995-997 Since human T lymphotropic virus (HTLV) infection was recently described in Israel and other Middle Eastern countries, we have investigated the presence of HTLV type 1 and type 2 in a group of 299 intravenous (IV) drug abusers who were seen at a large methadone clinic in the Tel Aviv area in 1986-1987. We found that 1.3{\%} were seropositive to HTLV. Further testing revealed that HTLV1 was the only HTLV serotype. In addition, no coinfection HIV1/HTLV1 and no HIV2 infection were detected. Since all HTLV s{\'e}ropositives were bom in Middle Eastern countries, did not travel outside Israel and were not infected by HIV1 or by HTLV type 2, it is possible that the source of HTLV1 infection in that group was in an endemic reservoir of HTLV1 in Israel. The detection of HTLV1 among IV drug abusers and among other groups in Israel necessitates more extensive HTLV testing in at-risk populations.",
author = "S. Maayan and M. Dan and R. Marline and Chen, {Y. M.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1093/ije/21.5.995",
language = "English",
volume = "21",
pages = "995--997",
journal = "International Journal of Epidemiology",
issn = "0300-5771",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Htlv among israeli intravenous drug abusers

AU - Maayan, S.

AU - Dan, M.

AU - Marline, R.

AU - Chen, Y. M.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Maayan S (Department of Clinical Microbiology, Hadassah University Hospital, Jerusalem, Israel), Dan M, Marlink R and Chen Y M. HTLV among Israeli intravenous drug abusers. International Journal of Epidemiology 1992; 21: 995-997 Since human T lymphotropic virus (HTLV) infection was recently described in Israel and other Middle Eastern countries, we have investigated the presence of HTLV type 1 and type 2 in a group of 299 intravenous (IV) drug abusers who were seen at a large methadone clinic in the Tel Aviv area in 1986-1987. We found that 1.3% were seropositive to HTLV. Further testing revealed that HTLV1 was the only HTLV serotype. In addition, no coinfection HIV1/HTLV1 and no HIV2 infection were detected. Since all HTLV séropositives were bom in Middle Eastern countries, did not travel outside Israel and were not infected by HIV1 or by HTLV type 2, it is possible that the source of HTLV1 infection in that group was in an endemic reservoir of HTLV1 in Israel. The detection of HTLV1 among IV drug abusers and among other groups in Israel necessitates more extensive HTLV testing in at-risk populations.

AB - Maayan S (Department of Clinical Microbiology, Hadassah University Hospital, Jerusalem, Israel), Dan M, Marlink R and Chen Y M. HTLV among Israeli intravenous drug abusers. International Journal of Epidemiology 1992; 21: 995-997 Since human T lymphotropic virus (HTLV) infection was recently described in Israel and other Middle Eastern countries, we have investigated the presence of HTLV type 1 and type 2 in a group of 299 intravenous (IV) drug abusers who were seen at a large methadone clinic in the Tel Aviv area in 1986-1987. We found that 1.3% were seropositive to HTLV. Further testing revealed that HTLV1 was the only HTLV serotype. In addition, no coinfection HIV1/HTLV1 and no HIV2 infection were detected. Since all HTLV séropositives were bom in Middle Eastern countries, did not travel outside Israel and were not infected by HIV1 or by HTLV type 2, it is possible that the source of HTLV1 infection in that group was in an endemic reservoir of HTLV1 in Israel. The detection of HTLV1 among IV drug abusers and among other groups in Israel necessitates more extensive HTLV testing in at-risk populations.

UR - http://www.scopus.com/inward/record.url?scp=0026468430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026468430&partnerID=8YFLogxK

U2 - 10.1093/ije/21.5.995

DO - 10.1093/ije/21.5.995

M3 - Article

C2 - 1468865

AN - SCOPUS:0026468430

VL - 21

SP - 995

EP - 997

JO - International Journal of Epidemiology

JF - International Journal of Epidemiology

SN - 0300-5771

IS - 5

ER -